FR2392017A1 - Derives de la 2h-pyrane-2,6(3h)-dione, leur procede de preparation et leur application en therapeutique - Google Patents

Derives de la 2h-pyrane-2,6(3h)-dione, leur procede de preparation et leur application en therapeutique

Info

Publication number
FR2392017A1
FR2392017A1 FR7814413A FR7814413A FR2392017A1 FR 2392017 A1 FR2392017 A1 FR 2392017A1 FR 7814413 A FR7814413 A FR 7814413A FR 7814413 A FR7814413 A FR 7814413A FR 2392017 A1 FR2392017 A1 FR 2392017A1
Authority
FR
France
Prior art keywords
pyrane
dione
derivatives
therapeutics
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7814413A
Other languages
English (en)
Other versions
FR2392017B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of FR2392017A1 publication Critical patent/FR2392017A1/fr
Application granted granted Critical
Publication of FR2392017B1 publication Critical patent/FR2392017B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Dérivés de substitution de la 2H-pyrane-2,6(3H)-dione, répondant à la formule :
FR7814413A 1977-05-23 1978-05-16 Derives de la 2h-pyrane-2,6(3h)-dione, leur procede de preparation et leur application en therapeutique Granted FR2392017A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79962577A 1977-05-23 1977-05-23

Publications (2)

Publication Number Publication Date
FR2392017A1 true FR2392017A1 (fr) 1978-12-22
FR2392017B1 FR2392017B1 (fr) 1982-06-18

Family

ID=25176371

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814413A Granted FR2392017A1 (fr) 1977-05-23 1978-05-16 Derives de la 2h-pyrane-2,6(3h)-dione, leur procede de preparation et leur application en therapeutique

Country Status (5)

Country Link
US (1) US4160021A (fr)
JP (1) JPS53144536A (fr)
DE (1) DE2821947A1 (fr)
FR (1) FR2392017A1 (fr)
GB (1) GB1593590A (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2280367A1 (fr) * 1974-07-29 1976-02-27 Smithkline Corp Derives de substitution de 2h-pyrane-2,6 (3h)-dione, leurs utilisations et leur preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4015009A (en) * 1974-10-02 1977-03-29 Smithkline Corporation Pharmaceutical compositions comprising substituted 3-cinnamoyl-2H-pyran-2,6(3H)-diones
US4017633A (en) * 1974-10-02 1977-04-12 Smithkline Corporation Substituted 3-(1-aminoethylidene)-5-cinnamoyl-2H-pyran-2,6(3H)-diones
US4032652A (en) * 1975-04-23 1977-06-28 Smithkline Corporation Substituted 2h-pyran-2,6(3h)-dione derivatives, pharmaceutical compositions comprising such derivatives and methods of inhibiting the antigen-antibody reaction
US4025642A (en) * 1975-12-03 1977-05-24 Smithkline Corporation Substituted 2H-pyran-2, 6(3H)-dione derivatives
US4025614A (en) * 1976-04-30 1977-05-24 Smithkline Corporation Substituted 2H-pyran-2,6 (3H)-dione derivatives useful in treatment of allergic reactions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2280367A1 (fr) * 1974-07-29 1976-02-27 Smithkline Corp Derives de substitution de 2h-pyrane-2,6 (3h)-dione, leurs utilisations et leur preparation

Also Published As

Publication number Publication date
JPS53144536A (en) 1978-12-15
DE2821947A1 (de) 1978-11-30
FR2392017B1 (fr) 1982-06-18
JPS6244551B2 (fr) 1987-09-21
GB1593590A (en) 1981-07-22
US4160021A (en) 1979-07-03

Similar Documents

Publication Publication Date Title
FR2392016A1 (fr) Derives de mevalonolactone, leur procede de preparation et leur application therapeutique
FR2385722A1 (fr) Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique
FR2383157A1 (fr) Derives de chalcone, leur procede de preparation et leur application en therapeutique
FR2383187A1 (fr) Derives du cepheme, leur procede de preparation et leur application en therapeutique
FR2364219A1 (fr) Derives de thiazolidine, leur procede de preparation et leur application en therapeutique
FR2406629A1 (fr) 5-trifluoromethylpyridines substituees en position 2 et leur procede de preparation
FR2381753A1 (fr) Nouveaux derives de la pyrrolidine, leur procede de preparation et leur application en therapeutique
FR2384811A1 (fr) Derives de la neocarzinostatine, leur application therapeutique et leur procede de preparation
FR2384783A1 (fr) Derives heteromonocycliques etheterobicycliques de l'acide 7 actylamido-3-cephem-4-carboxylique insature, procedes de preparation de ceux-ci, et utilisation en therapeutique
FR2421900A1 (fr) Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
FR2401161A1 (fr) Nouveaux derives de purine, leur preparation et leur application au traitement de la coccidiose
FR2387214A1 (fr) Derives du p-aminomethyl benzene-sulfonamide, leur procede de preparation et leur application therapeutique
FR2388804A1 (fr) Nouveaux derives des acides oxazole- et thiazole-alkanoiques et leur application en therapeutique humaine
FR2456097A1 (fr) Nouveaux derives de la 5 h-furanone-2 et de la 3 h-dihydrofuranone-2, leur procede de preparation et leur application en therapeutique
FR2383943A1 (fr) Triazinones, leur procede de preparation et leur application en therapeutique
FR2368489A1 (fr) Derives de la clavuline, leur procede de preparation et leur application en therapeutique
FR2392017A1 (fr) Derives de la 2h-pyrane-2,6(3h)-dione, leur procede de preparation et leur application en therapeutique
FR2390445A1 (fr) Nouveaux derives du chromene, leur procede de preparation et leurs applications en therapeutique
FR2397427A1 (fr) Derives de steroide et leur procede de preparation
FR2354312A2 (fr) Nouveaux derives de substitution du 1,3-diphenoxypropanol-(2) ainsi que leur procede de fabrication et leur application therapeutique
FR2379535A1 (fr) Nouveaux derives de l'ergoline, leurs applications en therapeutique et procede pour leur application
FR2381038A2 (fr) Nouveaux derives de la carbamoyloxymethyl-5 oxazolidinone-2 leur procede de preparation et leur application en therapeutique
FR2399406A1 (fr) Derives de perhydronaphtalenepentol et leur utilisation therapeutique
FR2390432A1 (fr) Benzene-sulfonyl urees, leur procede de preparation et leur application therapeutique
FR2400525A1 (fr) Nouveaux derives de 3-amino-17a-aza-d-homoandrostane, leur procede de preparation et les compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse